41 Stocks Moving In Monday's Mid-Day Session

Gainers

• Hunter Maritime Acquisition Corp. HUNT shares gained 58.3 percent to $14.80.
• Avaya Holdings Corp. AVYA jumped 36 percent to $17.96 following media reports the company is considering a leveraged buyout offer around $20 per share.
• Axsome Therapeutics, Inc. AXSM shares gained 20.4 percent to $15.65.
• Spark Networks SE LOV surged 14.5 percent to $14.25.
• Catalyst Pharmaceuticals Inc CPRX shares rose 14.2 percent to $4.59.
• Ascena Retail Group Inc ASNA gained 11.2 percent to $1.19 after the company announced it has agreed to sell a majority interest in its subsidiary Maurices to OpCapita for an expected $200 million.
• Urban Tea, Inc. MYT shares climbed 10.5 percent to $2.5749.
• Replimune Group, Inc. REPL gained 9.8 percent to $15.08.
• Iterum Therapeutics plc ITRM shares rose 8.7 percent to $7.90 after reporting upbeat Q4 results.
• Cyclacel Pharmaceuticals Inc CYCC gained 8.5 percent to $1.0199 after the company announced an independent investigation was published on the company's treatment.
• Krystal Biotech, Inc. KRYS rose 8.5 percent to $27.14 after gaining 4.25 percent on Friday.
• Yirendai Ltd – ADR YRD shares gained 8.4 percent to $12.41 after the company agreed with CreditEase to acquire certain business operations, including online wealth management. The company also reported mixed Q4 earnings.
• Check-Cap Ltd. CHEK shares jumped 8.1 percent to $3.0901.
• Conformis, Inc. CFMS rose 8 percent to $2.58.
• TIER REIT, Inc. TIER gained 7.8 percent to $27.46. Cousins Properties and TIER REIT agreed to merge in a 100 percent stock transaction.
• Central European Media Enterprises Ltd. CETV climbed 7.7 percent to $3.74 after the company announced it plans to review strategic alternatives.
• Trinity Biotech plc TRIB climbed 7.1 percent to $2.5700.
• Viacom Inc. VIAB rose 6.7 percent to $27.02 after the company reached an agreement with Directv to continue providing channels.
• Advaxis, Inc. ADXS climbed 5.6 percent to $0.5067 after the company was granted a US patent related to Axalimogene Filolisbac.

Check out these big penny stock gainers and losers

Losers

• Proteostasis Therapeutics, Inc. PTI shares tumbled 60.4 percent to $1.6100 after the company said a 14 day study of its Cystic Fibrosis treatment did not show improvement.
• Recro Pharma, Inc. REPH shares dipped 35.9 percent to $6.22 after the company's marketing application for IV Meloxicam was rejected by the FDA.
• Altisource Asset Management Corporation AAMC shares dropped 21.7 percent to $27.00.
• DarioHealth Corp. DRIO dipped 16.9 percent to $0.6791 after the company reported worse-than-expected Q4 sales.
• The9 Limited NCTY shares fell 15.9 percent to $2.1200 after signing a joint venture agreement with Faraday&Future to manufacture, market, distribute, and sell electric cars in China.
• Motif Bio plc MTFB fell 15.6 percent to $1.8983.
• Sorrento Therapeutics, Inc. SRNE fell 15 percent to $5.05 as the stock pulls back from a 155 percent climb in price last week.
• Phunware Inc. PHUN shares fell 14.6 percent to $38.00.
• Aqua Metals, Inc. AQMS shares declined 14.5 percent to $2.9588.
• Bio-Path Holdings, Inc. BPTH fell 13.5 percent to $19.01 after climbing 18.94 percent on Friday.
• Gridsum Holding Inc. GSUM shares fell 12.9 percent to $2.7100.
• Neuralstem, Inc. CUR dropped 11.6 percent to $0.5299. Neuralstem reported a net loss of $4.9 million, or $0.32 per share for the year ended December 31, 2018 for the year ended December 31, 2018, versus a year-ago loss of $15.7 million, or $1.20 per share.
• Key Energy Services, Inc. KEG dropped 11.5 percent to $4.24.
• Electrameccanica Vehicles Corp. SOLO fell 11.3 percent to $3.9550 after declining 8.79 percent on Friday.
• Riot Blockchain, Inc. RIOT shares declined 10.2 percent to $3.10.
• Criteo SA CRTO dropped 8.5 percent to $22.98.
• Lexicon Pharmaceuticals, Inc. LXRX tumbled 8.2 percent to $5.69. Gabelli & Co. upgraded Lexicon Pharmaceuticals from Sell to Hold.
• MannKind Corporation MNKD dropped 8.2 percent to $1.9550.
• Evolus, Inc. EOLS fell 7.9 percent to $22.12 after the company reported that it filed for a $250 million mixed shelf offering.
• AmpliPhi Biosciences Corporation APHB dipped 7.5 percent to $0.3054 after the company reported worse-than-expected Q4 EPS.
• Strongbridge Biopharma plc SBBP shares fell 7 percent to $4.7950.
• Nu Skin Enterprises, Inc. NUS dipped 6.7 percent to $45.99 after Stifel Nicolaus downgraded the company's stock from Hold to Sell and lowered its price target from $63 to $43 per share.